These 3 “Perfect 10” Stocks Are Compelling Plays In The Current Environment
“Against this backdrop, investors will need to crunch the numbers, to find the stocks that are best positioned for current conditions,” advises the author of…
davidgoldstein
Why A COVID-19 Vaccine Could Be Approved Before The November Election – And Who The Real Winners Would Be
Could a COVID-19 vaccine – or vaccines – be approved before the November election? That’s the bold prediction being made by Jefferies – and if…
Attractive Prices And Plenty Of Upside Make These 2 “Cutting Edge” Cancer Stocks Potential Buys
In the cancer treatment space, today’s article highlights two small-cap biotech names to consider this month based on their attractive prices and potential to “take…
What’s Behind The Irrational Trading In Bankrupt Stocks?
Recently, many bankrupt and near-bankrupt companies have experienced large price increases. What’s behind this seemingly very irrational trading behavior? The author of today’s article outlines…
“FastPharming” Could Help This Biotech In The Covid-19 Vaccine Race
“The challenge for investors who are looking to cash in on the hype surrounding a Covid-19 vaccine is placing their bets on the right horse,”…
Tap Tech With These Top-Performers
When it comes to the technology sector, today’s article notes it’s “booming and at the center of the current market rally. It has shown strong…
3 Top Picks In Small-Caps
“Shares of smaller companies are often volatile, but for investors willing to ride out the tug-of-war between greed and fear, these companies have strong growth…
A Loss Of Goodwill: Why It May Be Best To Avoid These 2 Healthcare Stocks
When it comes to acquisitions, “goodwill”, as the author of today’s article explains, “represents the premium an acquiring company paid over an acquisition target’s net…
The Birth Of “The Biotech Tourist”
“The search for a Covid-19 cure and an end to global shutdowns has created a new type of investor in health-care stocks: the biotech tourist,”…
Large And Small, These Biotech Stocks Could Be Big Winners
One large-cap biotech and two small-cap biotechs – one which “has been content with staying out of the limelight” and a second, higher-risk play –…